Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Uterine Cervical Neoplasms × Curcumin × Clear all

Phase

Status

Withdrawn 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Smoldering Multiple Myeloma 3 Prostatic Neoplasms 3 Monoclonal Gammopathy of Undetermined Significance 3 Multiple Myeloma 2 Uterine Cervical Neoplasms 1 Thrombocythemia, Essential 1 Stomach Neoplasms 1 Psychological Well-Being 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Myelodysplastic Syndromes 1 Motor Activity 1 Lung Neoplasms 1 Locally Advanced Cervical Cancer 1 Esophageal Neoplasms 1 Castration Sensitive Prostate Cancer 1

Interventions

pembrolizumab 17 Cisplatin 14 Carboplatin 10 Bevacizumab 9 Radiotherapy 8 Paclitaxel 8 Drug Therapy 7 Colposcopy 6 Brachytherapy 6 Blood Specimen Collection 6 Specimen Handling 5 camrelizumab 4 Nivolumab 4 Injections 4 Human Papillomavirus DNA Tests 4 Gemcitabine 4 Chemotherapy, Adjuvant 4 Chemoradiotherapy 4 toripalimab 3 Taxes 3 Surveys and Questionnaires 3 Mass Screening 3 Fulvestrant 3 Cyclophosphamide 3 Biopsy 3 zimberelimab 2 spartalizumab 2 lenvatinib 2 fludarabine 2 dostarlimab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05947513 2025-04-20

CuPRAC

Addis Ababa University

Phase NA Recruiting

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡